LSTA Q2 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$200

Operating Income

-$8M

Net Income

$39M

EPS (Diluted)

$65.10

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$72M

Total Liabilities

$18M

Stockholders' Equity

$54M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$8M	-100.0%
Gross Profit	-$200	$1M	-100.0%
Operating Income	-$8M	-$7M	-4.1%
Net Income	$39M	-$8M	+594.2%